Dowling & Yahnke’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-681
| Closed | -$397K | – | 338 |
|
|
2020
Q4 | $397K | Sell |
681
-74
| -10% | -$43.1K | 0.03% | 264 |
|
|
2020
Q3 | $389K | Buy |
755
+25
| +3% | +$12.9K | 0.03% | 252 |
|
|
2020
Q2 | $330K | Sell |
730
-6
| -0.8% | -$2.71K | 0.03% | 254 |
|
|
2020
Q1 | $258K | Sell |
736
-20
| -3% | -$7.01K | 0.02% | 262 |
|
|
2019
Q4 | $280K | Sell |
756
-50
| -6% | -$18.5K | 0.02% | 273 |
|
|
2019
Q3 | $268K | Buy |
806
+20
| +3% | +$6.65K | 0.02% | 272 |
|
|
2019
Q2 | $246K | Buy |
+786
| New | +$246K | 0.02% | 269 |
|
|
2018
Q4 | – | Sell |
-659
| Closed | -$206K | – | 264 |
|
|
2018
Q3 | $206K | Sell |
659
-268
| -29% | -$83.8K | 0.02% | 275 |
|
|
2018
Q2 | $267K | Hold |
927
| – | – | 0.02% | 254 |
|
|
2018
Q1 | $232K | Hold |
927
| – | – | 0.02% | 267 |
|
|
2017
Q4 | $221K | Sell |
927
-83
| -8% | -$19.8K | 0.02% | 276 |
|
|
2017
Q3 | $224K | Hold |
1,010
| – | – | 0.02% | 267 |
|
|
2017
Q2 | $229K | Hold |
1,010
| – | – | 0.02% | 261 |
|
|
2017
Q1 | $201K | Buy |
+1,010
| New | +$201K | 0.02% | 268 |
|